000892414 001__ 892414
000892414 005__ 20230111074307.0
000892414 0247_ $$2doi$$a10.3389/fmicb.2021.643275
000892414 0247_ $$2Handle$$a2128/29602
000892414 0247_ $$2altmetric$$aaltmetric:105405147
000892414 0247_ $$2pmid$$a34025604
000892414 0247_ $$2WOS$$aWOS:000651861700001
000892414 037__ $$aFZJ-2021-02070
000892414 082__ $$a570
000892414 1001_ $$0P:(DE-HGF)0$$aPietschmann, Jan$$b0
000892414 245__ $$aDevelopment of Fast and Portable Frequency Magnetic Mixing-Based Serological SARS-CoV-2-Specific Antibody Detection Assay
000892414 260__ $$aLausanne$$bFrontiers Media$$c2021
000892414 3367_ $$2DRIVER$$aarticle
000892414 3367_ $$2DataCite$$aOutput Types/Journal article
000892414 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1640268915_533
000892414 3367_ $$2BibTeX$$aARTICLE
000892414 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000892414 3367_ $$00$$2EndNote$$aJournal Article
000892414 520__ $$aA novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in China in December 2019, causing an ongoing, rapidly spreading global pandemic. Worldwide, vaccination is now expected to provide containment of the novel virus, resulting in an antibody-mediated immunity. To verify this, serological antibody assays qualitatively as well as quantitatively depicting the amount of generated antibodies are of great importance. Currently available test methods are either laboratory based or do not have the ability to indicate an estimation about the immune response. To overcome this, a novel and rapid serological magnetic immunodetection (MID) point-of-care (PoC) assay was developed, with sensitivity and specificity comparable to laboratory-based DiaSorin Liaison SARS-CoV-2 S1/S2 IgG assay. To specifically enrich human antibodies against SARS-CoV-2 in immunofiltration columns (IFCs) from patient sera, a SARS-CoV-2 S1 antigen was transiently produced in plants, purified and immobilized on the IFC. Then, an IgG-specific secondary antibody could bind to the retained antibodies, which was finally labeled using superparamagnetic nanoparticles. Based on frequency magnetic mixing technology (FMMD), the magnetic particles enriched in IFC were detected using a portable FMMD device. The obtained measurement signal correlates with the amount of SARS-CoV-2-specific antibodies in the sera, which could be demonstrated by titer determination. In this study, a MID-based assay could be developed, giving qualitative as well as semiquantitative results of SARS-CoV-2-specific antibody levels in patient’s sera within 21 min of assay time with a sensitivity of 97% and a specificity of 92%, based on the analysis of 170 sera from hospitalized patients that were tested using an Food and Drug Administration (FDA)-certified chemiluminescence assay.
000892414 536__ $$0G:(DE-HGF)POF3-523$$a523 - Controlling Configuration-Based Phenomena (POF3-523)$$cPOF3-523$$fPOF III$$x0
000892414 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000892414 7001_ $$0P:(DE-HGF)0$$aVoepel, Nadja$$b1
000892414 7001_ $$0P:(DE-HGF)0$$aVoß, Leonie$$b2
000892414 7001_ $$0P:(DE-HGF)0$$aRasche, Stefan$$b3
000892414 7001_ $$0P:(DE-HGF)0$$aSchubert, Max$$b4
000892414 7001_ $$0P:(DE-HGF)0$$aKleines, Michael$$b5
000892414 7001_ $$0P:(DE-Juel1)128697$$aKrause, Hans-Joachim$$b6$$ufzj
000892414 7001_ $$0P:(DE-HGF)0$$aShaw, Tamlyn M.$$b7
000892414 7001_ $$0P:(DE-HGF)0$$aSpiegel, Holger$$b8
000892414 7001_ $$0P:(DE-HGF)0$$aSchroeper, Florian$$b9$$eCorresponding author
000892414 773__ $$0PERI:(DE-600)2587354-4$$a10.3389/fmicb.2021.643275$$gVol. 12, p. 643275$$p643275$$tFrontiers in microbiology$$v12$$x1664-302X$$y2021
000892414 8564_ $$uhttps://juser.fz-juelich.de/record/892414/files/Paper%20%28open%20access%29.pdf$$yOpenAccess
000892414 909CO $$ooai:juser.fz-juelich.de:892414$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000892414 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Fraunhofer IME$$b0
000892414 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Fraunhofer IME$$b1
000892414 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)128697$$aForschungszentrum Jülich$$b6$$kFZJ
000892414 9130_ $$0G:(DE-HGF)POF3-523$$1G:(DE-HGF)POF3-520$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lFuture Information Technology - Fundamentals, Novel Concepts and Energy Efficiency (FIT)$$vControlling Configuration-Based Phenomena$$x0
000892414 9141_ $$y2021
000892414 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-27
000892414 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-27
000892414 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-01-27
000892414 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-27
000892414 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000892414 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT MICROBIOL : 2019$$d2021-01-27
000892414 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-01-27
000892414 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-01-27
000892414 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-27
000892414 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-01-27
000892414 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-27
000892414 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2021-01-27
000892414 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000892414 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-01-27
000892414 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-01-27
000892414 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-27
000892414 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2021-01-27
000892414 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-27
000892414 920__ $$lyes
000892414 9201_ $$0I:(DE-Juel1)IBI-3-20200312$$kIBI-3$$lBioelektronik$$x0
000892414 980__ $$ajournal
000892414 980__ $$aVDB
000892414 980__ $$aUNRESTRICTED
000892414 980__ $$aI:(DE-Juel1)IBI-3-20200312
000892414 9801_ $$aFullTexts